Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats

Kidney International

Volumn 87, Issue 6, 2015, Pages 1141-1152

  Ritter, Cynthia S ^a   Zhang, Sarah ^a   Delmez, James ^a   Finch, Jane L ^a   Slatopolsky, Eduardo ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aorta; Klotho; parathyroid; renal failure; uremic rats; VDRA

Indexed keywords

DENTIN MATRIX PROTEIN 1; IMMUNOGLOBULIN G; KLOTHO ANTIBODY; KLOTHO PROTEIN; PARICALCITOL; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VIMENTIN; BETA GLUCURONIDASE; BONE DENSITY CONSERVATION AGENT; ERGOCALCIFEROL;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; AORTA; ARTICLE; CALCIFICATION; CELL DIFFERENTIATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; HYPERPHOSPHATEMIA; KIDNEY; MACROPHAGE; NEPHRECTOMY; NONHUMAN; PARATHYROID GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY HYPERPARATHYROIDISM; THYROIDECTOMY; UBIQUITINATION; UPREGULATION; UREMIA; ANIMAL; CHEMISTRY; COMPLICATION; DISEASE MODEL; INTIMA; METABOLISM; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; SPRAGUE DAWLEY RAT; THYROID PARAFOLLICULAR CELL;

ADVENTITIA; ANIMALS; AORTA; BONE DENSITY CONSERVATION AGENTS; DISEASE MODELS, ANIMAL; ERGOCALCIFEROLS; FEMALE; FIBROBLASTS; GLUCURONIDASE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPHOSPHATEMIA; KIDNEY; NEPHRECTOMY; OXYPHIL CELLS; PARATHYROID GLANDS; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; TUNICA INTIMA; UREMIA;

EID: 84930273524     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.22     Document Type: Article

References (73)

1. Kuro-o M, Matsumura Y, Aizawa H et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45-51.
2. Mitobe M, Yoshida T, Sugiura H et al. Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol 2005; 101: e67-e74.
3. Hu MC, Shi M, Zhang J et al. Klotho: A novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010; 24: 3438-3450.
4. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V et al. The parathyroid is a target organ for fgf23 in rats. J Clin Invest 2007; 117: 4003-4008.
5. Zhou L, Li Y, Zhou D et al. Loss of klotho contributes to kidney injury by derepression of wnt/beta-catenin signaling. J Am Soc Nephrol 2013; 24: 771-785.
6. Lim K, Lu TS, Molostvov G et al. Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 2012; 125: 2243-2255.
7. Lau WL, Leaf EM, Hu MC et al. Vitamin d receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int 2012; 82: 1261-1270.
8. Fang Y, Ginsberg C, Sugatani T et al. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int 2014; 85: 142-150.
9. Donate-Correa J, Mora-Fernandez C, Martinez-Sanz R et al. Expression of fgf23/klotho system in human vascular tissue. Int J Cardiol 2013; 165: 179-183.
10. Scialla JJ, Lau WL, Reilly MP et al. Chronic Renal Insufficiency Cohort Study I. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 2013; 83: 1159-1168.
11. Jimbo R, Kawakami-Mori F, Mu S et al. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of klotho deficiency. Kidney Int 2013; 85: 1103-1111.
12. Lindberg K, Olauson H, Amin R et al. Arterial klotho expression and fgf23 effects on vascular calcification and function. PloS One 2013; 8: e60658.
13. Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical fgf receptor into a specific receptor for fgf23. Nature 2006; 444: 770-774.
14. Goetz R, Nakada Y, Hu MC et al. Isolated c-terminal tail of fgf23 alleviates hypophosphatemia by inhibiting fgf23-fgfr-klotho complex formation. Proc Natl Acad Sci U S A 2010; 107: 407-412.
15. Kurosu H, Ogawa Y, Miyoshi M et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 2006; 281: 6120-6123.
16. Kurosu H, Yamamoto M, Clark JD et al. Suppression of aging in mice by the hormone klotho. Science 2005; 309: 1829-1833.
17. Imura A, Tsuji Y, Murata M et al. Alpha-klotho as a regulator of calcium homeostasis. Science 2007; 316: 1615-1618.
18. Hu MC, Kuro OM, Moe OW. Renal and extrarenal actions of klotho. Semin Nephrol 2013; 33: 118-129.
19. Shimada T, Hasegawa H, Yamazaki Y et al. Fgf-23 is a potent regulator of vitamin d metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435.
20. Krajisnik T, Bjorklund P, Marsell R et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195: 125-131.
21. Teng M, Wolf M, Lowrie E et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349: 446-456.
22. Mizobuchi M, Nakamura H, Tokumoto M et al. Myocardial effects of vdr activators in renal failure. J Steroid Biochem Mol Biol 2010; 121: 188-192.
23. Forster RE, Jurutka PW, Hsieh JC et al. Vitamin d receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochem Biophys Res Commun 2011; 414: 557-562.
24. Koh N, Fujimori T, Nishiguchi S et al. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 2001; 280: 1015-1020.
25. Asai O, Nakatani K, Tanaka T et al. Decreased renal alpha-klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int 2012; 81: 539-547.
26. Sakan H, Nakatani K, Asai O et al. Reduced renal alpha-klotho expression in ckd patients and its effect on renal phosphate handling and vitamin d metabolism. PloS One 2014; 9: e86301.
27. Aizawa H, Saito Y, Nakamura T et al. Downregulation of the klotho gene in the kidney under sustained circulatory stress in rats. Biochem Biophys Res Commun 1998; 249: 865-871.
28. Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22: 124-136.
29. Ohyama Y, Kurabayashi M, Masuda H et al. Molecular cloning of rat klotho cdna: Markedly decreased expression of klotho by acute inflammatory stress. Biochem Biophys Res Commun 1998; 251: 920-925.
30. Sugiura H, Yoshida T, Mitobe M et al. Klotho reduces apoptosis in experimental ischaemic acute kidney injury via hsp-70. Nephrol Dial Transplant 2010; 25: 60-68.
31. Tan X, Li Y, Liu Y. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 2006; 17: 3382-3393.
32. Mizobuchi M, Morrissey J, Finch JL et al. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin d analog suppresses the progression of renal insufficiency in uremic rats. J Am Soc Nephrol 2007; 18: 1796-1806.
33. Kuhlmann A, Haas CS, Gross ML et al. 1,25-dihydroxyvitamin d3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol 2004; 286: F526-F533.
34. Makibayashi K, Tatematsu M, Hirata M et al. A vitamin d analog ameliorates glomerular injury on rat glomerulonephritis. Am J Pathol 2001; 158: 1733-1741.
35. Panichi V, Migliori M, Taccola D et al. Effects of 1,25(oh)2d3 in experimental mesangial proliferative nephritis in rats. Kidney Int 2001; 60: 87-95.
36. Schwarz U, Amann K, Orth SR et al. Effect of 1,25 (oh)2 vitamin d3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int 1998; 53: 1696-1705.
37. Teng M, Wolf M, Lowrie E et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349: 446-456.
38. Tentori F, Hunt WC, Stidley CA et al. Medical Directors of Dialysis Clinic I. Mortality risk among hemodialysis patients receiving different vitamin d analogs. Kidney Int 2006; 70: 1858-1865.
39. Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-1349.
40. Carrillo-Lopez N, Roman-Garcia P, Rodriguez-Rebollar A et al. Indirect regulation of pth by estrogens may require fgf23. J Am Soc Nephrol 2009; 20: 2009-2017.
41. Galitzer H, Ben-Dov IZ, Silver J et al. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 2010; 77: 211-218.
42. Hofman-Bang J, Martuseviciene G, Santini MA et al. Increased parathyroid expression of klotho in uremic rats. Kidney Int 2010; 78: 1119-1127.
43. Krajisnik T, Olauson H, Mirza MA et al. Parathyroid klotho and fgf-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int 2010; 78: 1024-1032.
44. Bjorklund P, Krajisnik T, Akerstrom G et al. Type i membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism. J Clin Endocrinol Metab 2008; 93: 4152-4157.
45. Latus J, Lehmann R, Roesel M et al. Involvement of alpha-klotho, fibroblast growth factor-, vitamin-d- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism. Endocrine 2013; 44: 255-263.
46. Ohkido I, Yokoyama K, Imura A et al. Persistent alpha-klotho (a-kl) expression in the parathyroid glands of patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2010; 25: 1007-1008; author reply 1008-1009.
47. Komaba H, Goto S, Fujii H et al. Depressed expression of klotho and fgf receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 2010; 77: 232-238.
48. Latus J, Lehmann R, Roesel M et al. Analysis of alpha-klotho, fibroblast growth factor-, vitamin-d and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism. Kidney Blood Press Res 2013; 37: 84-94.
49. Ritter CS, Haughey BH, Armbrecht HJ et al. Distribution and regulation of the 25-hydroxyvitamin d3 1alpha-hydroxylase in human parathyroid glands. J Steroid Biochem Mol Biol 2012; 130: 73-80.
50. Ritter CS, Haughey BH, Miller B et al. Differential gene expression by oxyphil and chief cells of human parathyroid glands. J Clin Endocrinol Metab 2012; 97: E1499-E1505.
51. Boquist L. Occurrence of oxyphil cells in suppressed parathyroid glands. Cell Tissue Res 1975; 163: 465-470.
52. Barai SR, Suryawanshi SA, Pandey AK. Responses of parathyroid gland, c cells, and plasma calcium and inorganic phosphate levels in rat to sublethal heroin administration. J Environ Biol 2009; 30: 917-922.
53. Rangoonwala SP, Suryawanshi SA, Pandey AK. Responses of serum calcium and inorganic phosphate levels as well as parathyroid gland and calcitonin producing c cells of rattus norvegicus to mipcin administration. J Environ Biol 2007; 28: 475-481.
54. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-S119.
55. Foley RN, Murray AM, Li S et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the united states medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495.
56. Wilson PW, Kauppila LI, O?Donnell CJ et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001; 103: 1529-1534.
57. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942.
58. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740.
59. Wang AY, Wang M, Woo J et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J Am Soc Nephrol 2003; 14: 159-168.
60. van Venrooij NA, Pereira RC, Tintut Y et al. Fgf23 protein expression in coronary arteries is associated with impaired kidney function. Nephrol Dial Transplant 2014; 29: 1525-1532.
61. Cozzolino M, Mehmeti F, Ciceri P et al. The effect of paricalcitol on vascular calcification and cardiovascular disease in uremia: Beyond PTH control. Int J Nephrol 2011; 2011: 269060.
62. Majesky MW, Dong XR, Hoglund V et al. The adventitia: A progenitor cell niche for the vessel wall. Cells Tissues Organs 2012; 195: 73-81.
63. Heistad DD, Marcus ML, Larsen GE et al. Role of vasa vasorum in nourishment of the aortic wall. Am J Physiol 1981; 240: H781-H787.
64. Hu Y, Zhang Z, Torsney E et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in apoe-deficient mice. J Clin Invest 2004; 113: 1258-1265.
65. Sartore S, Chiavegato A, Faggin E et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: From innocent bystander to active participant. Circ Res 2001; 89: 1111-1121.
66. Ballanti P, Silvestrini G, Pisano S et al. Medial artery calcification of uremic patients: A histological, histochemical and ultrastructural study. Histol Histopathol 2011; 26: 191-200.
67. Shao JS, Cheng SL, Pingsterhaus JM et al. Msx2 promotes cardiovascular calcification by activating paracrine wnt signals. J Clin Invest 2005; 115: 1210-1220.
68. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: An early perspective. Am J Physiol Endocrinol Metab 2004; 286: E686-E696.
69. Farinelli P, Arango-Gonzalez B, Volkl J et al. Retinitis pigmentosa: Overexpression of anti-ageing protein klotho in degenerating photoreceptors. J Neurochem 2013; 127: 868-879.
70. Xie H, Liu L, Shi W et al. Down regulation of cd147 boosts the premature senescence in human skin fibroblasts by destroying the redox balance and inhibiting klotho. J Dermatol Sci 2011; 64: 243-245.
71. Pasztoi M, Nagy G, Geher P et al. Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts. Arthritis Res Ther 2009; 11: R68.
72. de Oliveira RM. Klotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway. FEBS Lett 2006; 580: 5753-5758.
73. Gabbiani G, Schmid E, Winter S et al. Vascular smooth muscle cells differ from other smooth muscle cells: Predominance of vimentin filaments and a specific alpha-type actin. Proc Natl Acad Sci U S A 1981; 78: 298-302.